-
According to results from the 2013 Contraceptive Technology Update Contraception Survey, while many women continue to pick combined oral contraceptives (OCs), other options are making inroads on the popular choice.
-
Intimate partner violence (IPV) and reproductive and sexual coercion disproportionately affect women. Such behavior is aimed at establishing control of one partner over the other.
-
Women continue to choose long-acting reversible contraceptive (LARC) methods, say respondents to the 2013 Contraceptive Technology Update Contraception Survey.
-
Responses to the 2013 Contraceptive Technology Update Contraception Survey indicate that many clinicians have moved to remove one hurdle to contraception by adopting the Quick Start method of method initiation.
-
Results of the 2013 Contraceptive Technology Update Contraception Survey indicate that use of the NuvaRing contraceptive vaginal ring and the Evra contraceptive patch is consistent with 2012's figures.
-
We now have three options for emergency contraception the copper IUD, oral ulipristal acetate, and oral levonorgestrel. One of the most important considerations in using emergency contraception is the initiation of ongoing regular contraception. The special feature will discuss the opportunities and considerations for use of these three different methods of postcoital contraception.
-
A meta-analysis of 19 studies involving first trimester screening for fetal anomalies has shown that a majority of major structural abnormalities can be diagnosed between 11 and 14 weeks and that even cardiac abnormalities can be identified with ultrasound with reasonable efficiency.
-
Synopsis: In this study, women without allergies who consumed peanuts or tree nuts five times or more per month around the time of pregnancy compared to less than one time per month had reduced odds of having children with peanut or tree nut allergies.
-
The association between oral contraceptive use and ovarian or breast cancer in BRCA1 or BRCA2 mutation carriers are qualitatively similar to associations reported in the general population. Oral contraceptive pill use is inversely associated with ovarian cancer risk. However, it is also associated with a modest, but not statistically significant, increased risk for breast cancer. The analysis was unable to provide conclusive recommendations as to their use as preventive measures given these and other unmeasured risks. However, oral contraceptive pills appear safe for contraception in this population.
-
If you have any patients who use 28-day packages of Nortrel 7/7/7 oral contraceptives (OCs), be sure your clinic has initiated its patient notification plan following the July 9, 2003, voluntary recall issued by the pills manufacturer, Barr Laboratories of Pomona, NY.
